Beijing Scitop Bio-tech (300858) Stock Overview
Researches, develops, produces, and sells probiotic, postbiotics, and microecologival preparations for animals and plants in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
300858 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Beijing Scitop Bio-tech Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥16.65 |
| 52 Week High | CN¥24.66 |
| 52 Week Low | CN¥11.03 |
| Beta | 0.52 |
| 1 Month Change | -13.15% |
| 3 Month Change | -12.04% |
| 1 Year Change | -2.40% |
| 3 Year Change | -16.50% |
| 5 Year Change | -35.82% |
| Change since IPO | 31.72% |
Recent News & Updates
Recent updates
Investors Still Waiting For A Pull Back In Beijing Scitop Bio-tech Co., Ltd. (SZSE:300858)
Jan 05
Beijing Scitop Bio-tech (SZSE:300858) Will Want To Turn Around Its Return Trends
Nov 29Beijing Scitop Bio-tech Co., Ltd.'s (SZSE:300858) Earnings Haven't Escaped The Attention Of Investors
Sep 27Weak Statutory Earnings May Not Tell The Whole Story For Beijing Scitop Bio-tech (SZSE:300858)
Aug 27Beijing Scitop Bio-tech (SZSE:300858) Will Pay A Smaller Dividend Than Last Year
Jun 29Investor Optimism Abounds Beijing Scitop Bio-tech Co., Ltd. (SZSE:300858) But Growth Is Lacking
Apr 18Beijing Scitop Bio-tech (SZSE:300858) Is Reinvesting At Lower Rates Of Return
Mar 22Shareholder Returns
| 300858 | CN Food | CN Market | |
|---|---|---|---|
| 7D | -4.2% | -1.4% | 0.3% |
| 1Y | -2.4% | -2.5% | 16.8% |
Return vs Industry: 300858 exceeded the CN Food industry which returned -5.2% over the past year.
Return vs Market: 300858 underperformed the CN Market which returned 13.6% over the past year.
Price Volatility
| 300858 volatility | |
|---|---|
| 300858 Average Weekly Movement | 4.8% |
| Food Industry Average Movement | 4.2% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in CN Market | 9.0% |
| 10% least volatile stocks in CN Market | 3.0% |
Stable Share Price: 300858 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300858's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 295 | Xiaojun Liu | www.scitop.cn |
Beijing Scitop Bio-tech Co., Ltd. researches, develops, produces, and sells probiotic, postbiotics, and microecologival preparations for animals and plants in China. It provides probiotic and postbiotics for gastrointestinal health, immune regulation, oral health, sleep aid and stress relief, women’s health, slimming and fat reduction, kidney and liver protection, blood sugar regulation, allergy relief, blood pressure regulation, and mother-infant transmission, as well as exercise, bone, heart, and skin health applications. The company also offers microecological preparations and related application technologies for ruminants, monogastric livestock and poultry animals, aquatic animals, and pets.
Beijing Scitop Bio-tech Co., Ltd. Fundamentals Summary
| 300858 fundamental statistics | |
|---|---|
| Market cap | CN¥4.39b |
| Earnings (TTM) | CN¥99.40m |
| Revenue (TTM) | CN¥351.47m |
Is 300858 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300858 income statement (TTM) | |
|---|---|
| Revenue | CN¥351.47m |
| Cost of Revenue | CN¥154.36m |
| Gross Profit | CN¥197.11m |
| Other Expenses | CN¥97.71m |
| Earnings | CN¥99.40m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.38 |
| Gross Margin | 56.08% |
| Net Profit Margin | 28.28% |
| Debt/Equity Ratio | 0% |
How did 300858 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/12 03:06 |
| End of Day Share Price | 2025/12/12 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Beijing Scitop Bio-tech Co., Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wendan Wang | China International Capital Corporation Limited |